PCAS : Participation de PCAS au Forum d’affaires France-Chine à Paris le 1er juillet 2015

PCAS takes part in the China-France

Business Forum held in Paris on July 1st, 2015

During the official visit of China's Prime Minister Mr. Li Keqiang to France, PCAS (Euronext Paris: PCA), a specialist in the development and production of complex molecules for life sciences and innovative technologies, took part in the China-France Business Forum held on July 1, 2015 in Paris at the Ministry of the Economy, Industry and the Digital Sector, in the presence of former Prime Minister Mr. Jean-Pierre Raffarin.
Organized by Bank of China and Mr. Tian Guoli, Chairman of Bank of China, the forum provided PCAS with the ideal opportunity to meet a major delegation of Chinese companies, with the aim of increasing the number of business and partnership opportunities. Messrs. Christian Moretti, Vincent Touraille, Eric Moissenot, Didier Combis and Mathieu Tse represented PCAS at the forum.
PCAS has been commercially active in China since 2010 and is determined to strengthen the close links that it has already forged with Chinese companies, while developing its activities in a fast-growing market, especially in healthcare, advanced specialty chemicals and performance fine chemicals.
Bank of China has been a financial partner to PCAS in China since 2014.

Founded in 1912, BOC is one of China's leading banks and above all the banks with the greatest international presence. Bank of China offers an end-to-end range of financial services and delivers support
to major groups, SMEs, small and medium industries and mid-sized businesses, while encouraging French investment in China (as well as Chinese investment in France).

PCAS specialises in the development and production of complex molecules for Life Sciences and Innovative Technologies. With 7% of its turnover dedicated to R&D and a wide international presence, PCAS is the preferred industrial partner of market-leading major global groups. The company offers a growing range of proprietary products and solutions in leading-edge segments, and also includes two subsidiaries with very strong potential: Protéus in biotechnology and Enersens in high-performance insulation. With a particularly high standard of performance, PCAS achieved net sales of €166 million in 2014 and employs nearly 900 people in six countries.

To find out more about PCAS, visit www.pcas.com

distributed by